Jefferies Maintains a 'Buy' on Dynavax Technologies (DVAX); Next Catalyst For Heplisav
Tweet Send to a Friend
Jefferies maintains a 'Buy' on Dynavax Technologies (NASDAQ: DVAX) price target of $6.00.
Analyst, Thomas Wei, said, "DVAX announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Thomas Wei, said, "DVAX announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
